These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 28122084)
21. Delivering healthy mitochondria for the therapy of mitochondrial diseases and beyond. Liu CS; Chang JC; Kuo SJ; Liu KH; Lin TT; Cheng WL; Chuang SF Int J Biochem Cell Biol; 2014 Aug; 53():141-6. PubMed ID: 24842105 [TBL] [Abstract][Full Text] [Related]
22. Draft UK regulations for mitochondrial donation are published. Wise J BMJ; 2014 Feb; 348():g1846. PubMed ID: 24585821 [No Abstract] [Full Text] [Related]
23. When powerhouses fail. Westly E Nat Med; 2010 Jun; 16(6):625-7. PubMed ID: 20526309 [TBL] [Abstract][Full Text] [Related]
24. Audio interview: expanding federal funding for embryonic stem-cell research. Interview by Rachel Gotbaum. Hatch OG N Engl J Med; 2007 May; 356(18):e18. PubMed ID: 17452439 [No Abstract] [Full Text] [Related]
26. Approaches and limitations to gene therapy for mitochondrial diseases. Owen R; Flotte TR Antioxid Redox Signal; 2001 Jun; 3(3):451-60. PubMed ID: 11491656 [TBL] [Abstract][Full Text] [Related]
27. UK embryo licence draws global attention. Check E Nature; 2005 Sep; 437(7057):305. PubMed ID: 16163315 [No Abstract] [Full Text] [Related]
28. Scientific and Ethical Issues in Mitochondrial Donation. Craven L; Murphy J; Turnbull DM; Taylor RW; Gorman GS; McFarland R New Bioeth; 2018 Apr; 24(1):57-73. PubMed ID: 29529980 [TBL] [Abstract][Full Text] [Related]
29. Moving human embryonic stem cells from legislature to lab: remaining legal and ethical questions. Greely HT PLoS Med; 2006 Feb; 3(5):e143. PubMed ID: 16492089 [TBL] [Abstract][Full Text] [Related]
30. Mitochondrial replacement: from basic research to assisted reproductive technology portfolio tool-technicalities and possible risks. Cree L; Loi P Mol Hum Reprod; 2015 Jan; 21(1):3-10. PubMed ID: 25425606 [TBL] [Abstract][Full Text] [Related]
31. "Show me" bioethics and politics. Christopher MJ Am J Bioeth; 2007 Oct; 7(10):28-33. PubMed ID: 17926217 [TBL] [Abstract][Full Text] [Related]
32. Easing US restrictions on mitochondrial replacement therapy would protect research interests but grease the slippery slope. Keefe DL J Assist Reprod Genet; 2019 Sep; 36(9):1781-1785. PubMed ID: 31463871 [No Abstract] [Full Text] [Related]
33. Preventing Mitochondrial DNA Diseases: One Step Forward, Two Steps Back. Cohen IG; Adashi EY JAMA; 2016 Jul; 316(3):273-4. PubMed ID: 27280528 [No Abstract] [Full Text] [Related]
35. Bioethics and the political distortion of biomedical science. Blackburn E N Engl J Med; 2004 Apr; 350(14):1379-80. PubMed ID: 15070784 [No Abstract] [Full Text] [Related]
38. Commissions, Consensus, and CRISPR. Barrangou R CRISPR J; 2020 Oct; 3(5):316-317. PubMed ID: 33095046 [No Abstract] [Full Text] [Related]
39. The ethical implications of human cloning. Sandel MJ Perspect Biol Med; 2005; 48(2):241-7. PubMed ID: 15834196 [No Abstract] [Full Text] [Related]
40. What does the British public think about human-animal hybrid embryos? Jones DA J Med Ethics; 2009 Mar; 35(3):168-70. PubMed ID: 19251967 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]